XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Apr. 01, 2023
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the three month period ended April 1, 2023 was as follows:

 

   Shares   Weighted Average Grant Fair Value 
Balance, December 31, 2022   1,965,901   $2.22 
Granted   200,294    1.31 
Forfeited   (617,750)   3.20 
Vested   (17,500)   1.26 
Balance, April 1, 2023   1,530,945   $1.72 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended April 1, 2023 and March 26, 2022 (no tax benefits were recognized):

  

   Three Months
Ended
   Three Months
Ended
 
   April 1, 2023   March 26, 2022 
Cost of product revenues  $26,218   $66,668 
Research and development   16,874    147,379 
Selling, general and administrative   151,098    442,026 
Total  $194,190   $656,073